» Articles » PMID: 22015597

Microglia Isolated from Patients with Glioma Gain Antitumor Activities on Poly (I:C) Stimulation

Overview
Journal Neuro Oncol
Specialties Neurology
Oncology
Date 2011 Oct 22
PMID 22015597
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

The role of microglia, the brain-resident macrophages, in glioma biology is still a matter of debate. Clinical observations and in vitro studies in the mouse model indicate that microglia and macrophages that infiltrate the brain tumor tissue in high numbers play a tumor-supportive role. Here, we provide evidence that human microglia isolated from brain tumors indeed support tumor cell growth, migration, and invasion. However, after stimulation with the Toll-like receptor 3 agonist poly (I:C), microglia secrete factors that exerted toxic and suppressive effects on different glioblastoma cell lines, as assessed in cytotoxicity, migration, and tumor cell spheroid invasion assays. Remarkably, these effects were tumor-specific because the microglial factors impaired neither growth nor viability of astrocytes and neurons. Culture supernatants of tumor cells inhibited the poly (I:C) induction of this microglial M1-like, oncotoxic profile. Microglia stimulation before coculture with tumor cells circumvented the tumor-mediated suppression, as demonstrated by the ability to kill and phagocytose glioma cells. Our results show, for the first time to our knowledge, that human microglia exert tumor-supporting functions that are overridden by tumor-suppressing activities gained after poly (I:C) stimulation.

Citing Articles

Neuroimmune-competent human brain organoid model of diffuse midline glioma.

Sarnow K, Majercak E, Qurbonov Q, Cruzeiro G, Jeong D, Haque I Neuro Oncol. 2024; 27(2):369-382.

PMID: 39561098 PMC: 11812031. DOI: 10.1093/neuonc/noae245.


Phagocytosis Checkpoints in Glioblastoma: CD47 and Beyond.

Afzal A, Afzal Z, Bizink S, Davis A, Makahleh S, Mohamed Y Curr Issues Mol Biol. 2024; 46(8):7795-7811.

PMID: 39194679 PMC: 11352848. DOI: 10.3390/cimb46080462.


Glioma-derived ANXA1 suppresses the immune response to TLR3 ligands by promoting an anti-inflammatory tumor microenvironment.

Zheng Y, Jiang H, Yang N, Shen S, Huang D, Jia L Cell Mol Immunol. 2023; 21(1):47-59.

PMID: 38049523 PMC: 10757715. DOI: 10.1038/s41423-023-01110-0.


Myeloidcells in the immunosuppressive microenvironment in glioblastoma: The characteristics and therapeutic strategies.

Huang B, Zhang J, Zong W, Chen S, Zong Z, Zeng X Front Immunol. 2023; 14:994698.

PMID: 36923402 PMC: 10008967. DOI: 10.3389/fimmu.2023.994698.


Interrogating glioma-M2 macrophage interactions identifies Gal-9/Tim-3 as a viable target against -null glioblastoma.

Ni X, Wu W, Sun X, Ma J, Yu Z, He X Sci Adv. 2022; 8(27):eabl5165.

PMID: 35857445 PMC: 9269888. DOI: 10.1126/sciadv.abl5165.


References
1.
Komohara Y, Ohnishi K, Kuratsu J, Takeya M . Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas. J Pathol. 2008; 216(1):15-24. DOI: 10.1002/path.2370. View

2.
Zitvogel L, Kepp O, Kroemer G . Decoding cell death signals in inflammation and immunity. Cell. 2010; 140(6):798-804. DOI: 10.1016/j.cell.2010.02.015. View

3.
Herold-Mende C, Seiter S, Born A, Patzelt E, Schupp M, Zoller J . Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck. J Pathol. 1996; 179(1):66-73. DOI: 10.1002/(SICI)1096-9896(199605)179:1<66::AID-PATH544>3.0.CO;2-5. View

4.
Campos B, Wan F, Farhadi M, Ernst A, Zeppernick F, Tagscherer K . Differentiation therapy exerts antitumor effects on stem-like glioma cells. Clin Cancer Res. 2010; 16(10):2715-28. DOI: 10.1158/1078-0432.CCR-09-1800. View

5.
Remels L, Fransen L, Huygen K, De Baetselier P . Poly I:C activated macrophages are tumoricidal for TNF-alpha-resistant 3LL tumor cells. J Immunol. 1990; 144(11):4477-86. View